U.S. market Open. Closes in 5 hours 23 minutes

IRWD | Ironwood Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue442.74M410.60M413.75M389.52M428.41M346.64M298.28M273.96M149.56M76.44M22.88M150.25M65.87M43.86M36.10M22.22M10.46M
Cost of Revenue1.57M1.42M1.52M3.14M23.88M32.75M19.41M1.87M12.00K25.58M7.20M965.00KN/AN/AN/AN/AN/A
Gross Profit441.16M409.18M412.23M386.39M404.54M313.89M278.87M272.09M149.54M50.85M15.68M149.28M65.87M43.86M36.10M22.22M10.46M
Operating Expenses1.28B160.26M181.54M228.06M287.49M415.90M387.56M313.75M233.99M220.22M267.68M222.04M132.01M104.62M108.87M78.14M68.08M
Selling, General & Admin158.31M115.99M111.13M140.00M172.45M241.29M233.12M173.28M125.25M118.33M123.23M92.54M45.92M27.17M23.98M18.33M10.83M
Research & Development116.08M44.27M70.41M88.06M115.04M166.50M148.23M139.49M108.75M101.89M102.38M113.47M86.09M77.45M84.89M59.81M57.25M
Other Operating ExpensesN/AN/AN/A24.00K514.00K8.11M6.21M981.00K17.64M661.00K42.07M16.03MN/AN/A23.98M18.33M10.83M
Operating Income-945.43M250.34M232.26M142.94M120.12M-238.89M-77.39M-51.87M-102.09M-169.37M-252.00M-72.76M-66.14M-60.77M-72.77M-55.92M-57.62M
Other Expenses / Income-2.64M2.08M-31.60M-34.08M-61.18M-43.48M-71.16M-29.84M-40.58M-20.25M-20.81M138.00K1.29M1.41M-838.00K890.00K4.46M
Before Tax Income-948.07M252.42M200.66M108.86M58.94M-282.37M-116.94M-81.71M-142.67M-189.62M-272.81M-72.62M-64.85M-59.35M-73.61M-55.03M-53.16M
Income Tax Expenses83.49M77.36M-327.79M2.69M74.26M-5.75M34.26M37.98M19.02M8.58M-11.73M-11.32M3.00K-2.94M-296.00K-823.00K-145.00K
Net Income-1.00B175.06M528.45M106.18M-15.31M-282.37M-116.94M-81.71M-142.67M-189.62M-272.81M-72.62M-64.85M-52.98M-71.19M-53.87M-52.75M
Interest Expenses21.63M7.60M31.15M29.48M36.60M34.73M34.26M37.98M30.65M21.17M21.00M59.00K63.00K196.00K474.00K334.00K263.00K
Basic Shares Outstanding155.44M154.37M162.25M159.43M156.02M152.63M148.42M144.93M142.16M136.81M115.85M106.40M99.88M89.65M7.12M6.89M7.12M
Diluted Shares Outstanding155.44M186.31M164.42M160.66M156.02M152.63M148.99M145.91M142.16M136.81M115.85M106.40M99.88M89.65M75.57M6.89M75.57M
EBITDA-924.86M261.44M233.33M141.90M101.12M-144.45M-33.12M-31.30M-99.94M-156.12M-240.08M-61.24M-54.79M-53.00M-67.28M-51.85M-51.17M
EBITDA Margin-208.90%63.67%56.39%36.43%23.60%-41.67%-11.10%-11.42%-66.83%-204.25%-1,049.26%-40.76%-83.17%-120.84%-186.35%-233.38%-488.97%
EBIT-897.12M260.02M231.81M138.34M95.55M-253.39M-48.42M-5.74M-92.99M-159.87M-263.54M-83.89M-64.79M-55.73M-71.01M-54.36M-52.63M
EBIT Margin-202.63%63.33%56.03%35.51%22.30%-73.10%-16.23%-2.10%-62.18%-209.16%-1,151.78%-55.84%-98.35%-127.07%-196.68%-244.70%-503.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙